메뉴 건너뛰기




Volumn 349, Issue , 2014, Pages

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: A systematic review and meta-analysis

Author keywords

[No Author keywords available]

Indexed keywords

CANGRELOR; CLOPIDOGREL; PRASUGREL; THIENOPYRIDINE DERIVATIVE; TICAGRELOR; ANTITHROMBOCYTIC AGENT; PYRIDINE DERIVATIVE;

EID: 84908194227     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g6269     Document Type: Article
Times cited : (82)

References (64)
  • 1
    • 77954480782 scopus 로고    scopus 로고
    • The global registry of acute coronary events, 1999 to 2009-grace
    • Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA. The global registry of acute coronary events, 1999 to 2009-grace. Heart 2010;96:1095-101.
    • (2010) Heart , vol.96 , pp. 1095-1101
    • Fox, K.A.1    Eagle, K.A.2    Gore, J.M.3    Steg, P.G.4    Anderson, F.A.5
  • 2
    • 33749000304 scopus 로고    scopus 로고
    • The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the mediterranean basin in 2004
    • Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean basin in 2004. Eur Heart J 2006;27:2285-93.
    • (2006) Eur Heart J , vol.27 , pp. 2285-2293
    • Mandelzweig, L.1    Battler, A.2    Boyko, V.3    Bueno, H.4    Danchin, N.5    Filippatos, G.6
  • 3
    • 0033599277 scopus 로고    scopus 로고
    • Prognostic value of the admission electrocardiogram in acute coronary syndromes
    • Savonitto S, Ardissino D, Granger CB, Morando G, Prando MD, Mafrici A, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999;281:707-13.
    • (1999) JAMA , vol.281 , pp. 707-713
    • Savonitto, S.1    Ardissino, D.2    Granger, C.B.3    Morando, G.4    Prando, M.D.5    Mafrici, A.6
  • 4
    • 77953577951 scopus 로고    scopus 로고
    • Population trends in the incidence and outcomes of acute myocardial infarction
    • Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010;362:2155-65.
    • (2010) N Engl J Med , vol.362 , pp. 2155-2165
    • Yeh, R.W.1    Sidney, S.2    Chandra, M.3    Sorel, M.4    Selby, J.V.5    Go, A.S.6
  • 5
    • 13544256553 scopus 로고    scopus 로고
    • Mortality rates in patients with ST-elevation vs. Non-St-elevation acute myocardial infarction: Observations from an unselected cohort
    • Terkelsen CJ, Lassen JF, Norgaard BL, Gerdes JC, Jensen T, Gotzsche LB, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 2005;26:18-26.
    • (2005) Eur Heart J , vol.26 , pp. 18-26
    • Terkelsen, C.J.1    Lassen, J.F.2    Norgaard, B.L.3    Gerdes, J.C.4    Jensen, T.5    Gotzsche, L.B.6
  • 6
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
    • (2001) N Engl J Med , vol.345 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3    Chrolavicius, S.4    Tognoni, G.5    Fox, K.K.6
  • 7
    • 33644587565 scopus 로고    scopus 로고
    • Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention
    • Steinhubl SR, Berger PB, Brennan DM, Topol EJ. Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention. J Am Coll Cardiol 2006;47:939-43.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 939-943
    • Steinhubl, S.R.1    Berger, P.B.2    Brennan, D.M.3    Topol, E.J.4
  • 8
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
    • Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20.
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.R.1    Berger, P.B.2    Mann, J.T.3    Fry, E.T.4    DeLago, A.5    Wilmer, C.6
  • 9
    • 33645982865 scopus 로고    scopus 로고
    • High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
    • Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 2006;4:542-9.
    • (2006) J Thromb Haemost , vol.4 , pp. 542-549
    • Cuisset, T.1    Frere, C.2    Quilici, J.3    Barbou, F.4    Morange, P.E.5    Hovasse, T.6
  • 10
    • 8344221349 scopus 로고    scopus 로고
    • Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
    • Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-5.
    • (2004) Circulation , vol.109 , pp. 3171-3175
    • Matetzky, S.1    Shenkman, B.2    Guetta, V.3    Shechter, M.4    Beinart, R.5    Goldenberg, I.6
  • 11
    • 0038649988 scopus 로고    scopus 로고
    • Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
    • Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13.
    • (2003) Circulation , vol.107 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3    O'Connor, C.M.4
  • 13
    • 84856158305 scopus 로고    scopus 로고
    • ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
    • Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
    • (2011) Eur Heart J , vol.32 , pp. 2999-3054
    • Hamm, C.W.1    Bassand, J.P.2    Agewall, S.3    Bax, J.4    Boersma, E.5    Bueno, H.6
  • 14
    • 84865271531 scopus 로고    scopus 로고
    • 2012 Accf/aha focused update of the guideline for the management of patients with unstable angina/non-St-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): A report of the American College of Cardiology foundation/American Heart Association Task Force on practice guidelines
    • Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2012;126:875-910.
    • (2012) Circulation , vol.126 , pp. 875-910
    • Jneid, H.1    Anderson, J.L.2    Wright, R.S.3    Adams, C.D.4    Bridges, C.R.5    Casey, D.E.6
  • 15
    • 84874366583 scopus 로고    scopus 로고
    • Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: A systematic review and meta-analysis
    • Navarese EP, Gurbel PA, Andreotti F, Tantry U, Jeong YH, Kozinski ME, et al. Optimal timing of coronary invasive strategy in non-st-segment elevation acute coronary syndromes: A systematic review and meta-analysis. Ann Intern Med 2013;158:261-70.
    • (2013) Ann Intern Med , vol.158 , pp. 261-270
    • Navarese, E.P.1    Gurbel, P.A.2    Andreotti, F.3    Tantry, U.4    Jeong, Y.H.5    Kozinski, M.E.6
  • 16
    • 33745685673 scopus 로고    scopus 로고
    • Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery
    • Mehta RH, Roe MT, Mulgund J, Ohman EM, Cannon CP, Gibler WB, et al. Acute clopidogrel use and outcomes in patients with non-st-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 2006;48:281-6.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 281-286
    • Mehta, R.H.1    Roe, M.T.2    Mulgund, J.3    Ohman, E.M.4    Cannon, C.P.5    Gibler, W.B.6
  • 17
    • 84857440263 scopus 로고    scopus 로고
    • Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational studies
    • Biancari F, Airaksinen KE, Lip GY. Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. J Thorac Cardiovasc Surg 2012;143:665-75.
    • (2012) J Thorac Cardiovasc Surg , vol.143 , pp. 665-675
    • Biancari, F.1    Airaksinen, K.E.2    Lip, G.Y.3
  • 18
    • 0035887138 scopus 로고    scopus 로고
    • Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)
    • A886
    • Assali AR, Salloum J, Sdringola S, Moustapha A, Ghani M, Hale S, et al. Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban). Am J Cardiol 2001;88:884-6, A886.
    • (2001) Am J Cardiol , vol.88 , pp. 884-886
    • Assali, A.R.1    Salloum, J.2    Sdringola, S.3    Moustapha, A.4    Ghani, M.5    Hale, S.6
  • 19
    • 77955640907 scopus 로고    scopus 로고
    • Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: Results of the armyda-5 PRELOAD (Antiplatelet therapy for reduction of myocardial damage during Angioplasty) randomized trial
    • Di Sciascio G, Patti G, Pasceri V, Gatto L, Colonna G, Montinaro A. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the armyda-5 PRELOAD (Antiplatelet therapy for reduction of myocardial damage during Angioplasty) randomized trial. J Am Coll Cardiol 2010;56:550-7.
    • (2010) J Am Coll Cardiol , vol.56 , pp. 550-557
    • Di Sciascio, G.1    Patti, G.2    Pasceri, V.3    Gatto, L.4    Colonna, G.5    Montinaro, A.6
  • 21
    • 84871313410 scopus 로고    scopus 로고
    • Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis
    • Bellemain-Appaix A, O'Connor SA, Silvain J, Cucherat M, Beygui F, Barthelemy O, et al. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. JAMA 2012;308:2507-16.
    • (2012) JAMA , vol.308 , pp. 2507-2516
    • Bellemain-Appaix, A.1    O'Connor, S.A.2    Silvain, J.3    Cucherat, M.4    Beygui, F.5    Barthelemy, O.6
  • 22
    • 78049347838 scopus 로고    scopus 로고
    • New p2y12 inhibitors versus clopidogrel in percutaneous coronary intervention: A meta-analysis
    • Bellemain-Appaix A, Brieger D, Beygui F, Silvain J, Pena A, Cayla G, et al. New p2y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis. J Am Coll Cardiol 2010;56:1542-51.
    • (2010) J Am Coll Cardiol , vol.56 , pp. 1542-1551
    • Bellemain-Appaix, A.1    Brieger, D.2    Beygui, F.3    Silvain, J.4    Pena, A.5    Cayla, G.6
  • 23
    • 84859001212 scopus 로고    scopus 로고
    • The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
    • Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
    • (2011) BMJ , vol.343 , pp. d5928
    • Higgins, J.P.1    Altman, D.G.2    Gotzsche, P.C.3    Juni, P.4    Moher, D.5    Oxman, A.D.6
  • 25
    • 74249086287 scopus 로고    scopus 로고
    • Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes
    • Feldman DN, Fakorede F, Minutello RM, Bergman G, Moussa I, Wong SC. Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2010;105:323-32.
    • (2010) Am J Cardiol , vol.105 , pp. 323-332
    • Feldman, D.N.1    Fakorede, F.2    Minutello, R.M.3    Bergman, G.4    Moussa, I.5    Wong, S.C.6
  • 26
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
    • Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-33.
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.3    Bertrand, M.E.4    Lewis, B.S.5    Natarajan, M.K.6
  • 27
    • 33947187284 scopus 로고    scopus 로고
    • Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
    • Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 2007;369:907-19.
    • (2007) Lancet , vol.369 , pp. 907-919
    • Stone, G.W.1    White, H.D.2    Ohman, E.M.3    Bertrand, M.E.4    Lincoff, A.M.5    McLaurin, B.T.6
  • 28
    • 50249086970 scopus 로고    scopus 로고
    • Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-Year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategy) trial
    • White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, et al. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategy) trial. J Am Coll Cardiol 2008;52:807-14.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 807-814
    • White, H.D.1    Ohman, E.M.2    Lincoff, A.M.3    Bertrand, M.E.4    Colombo, A.5    McLaurin, B.T.6
  • 29
    • 3242785367 scopus 로고    scopus 로고
    • Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: Results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)
    • Chan AW, Moliterno DJ, Berger PB, Stone GW, DiBattiste PM, Yakubov SL, et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: Results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol 2003;42:1188-95.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1188-1195
    • Chan, A.W.1    Moliterno, D.J.2    Berger, P.B.3    Stone, G.W.4    DiBattiste, P.M.5    Yakubov, S.L.6
  • 30
    • 0035853027 scopus 로고    scopus 로고
    • Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial
    • Steinhubl SR, Ellis SG, Wolski K, Lincoff AM, Topol EJ. Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. Circulation 2001;103:1403-9.
    • (2001) Circulation , vol.103 , pp. 1403-1409
    • Steinhubl, S.R.1    Ellis, S.G.2    Wolski, K.3    Lincoff, A.M.4    Topol, E.J.5
  • 31
    • 45849150315 scopus 로고    scopus 로고
    • Clopidogrel pre-treatment in stable angina: For all patients > 6 h before elective coronary angiography or only for angiographically selected patients A few minutes before PCI? A randomized multicentre trial prague-8
    • Widimsky P, Motovska Z, Simek S, Kala P, Pudil R, Holm F, et al. Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8. Eur Heart J 2008;29:1495-503.
    • (2008) Eur Heart J , vol.29 , pp. 1495-1503
    • Widimsky, P.1    Motovska, Z.2    Simek, S.3    Kala, P.4    Pudil, R.5    Holm, F.6
  • 32
    • 77958005516 scopus 로고    scopus 로고
    • Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial
    • Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010;376:1233-43.
    • (2010) Lancet , vol.376 , pp. 1233-1243
    • Mehta, S.R.1    Tanguay, J.F.2    Eikelboom, J.W.3    Jolly, S.S.4    Joyner, C.D.5    Granger, C.B.6
  • 33
    • 69849102432 scopus 로고    scopus 로고
    • Immediate vs delayed intervention for acute coronary syndromes: A randomized clinical trial
    • Montalescot G, Cayla G, Collet JP, Elhadad S, Beygui F, Le Breton H, et al. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. JAMA 2009;302:947-54.
    • (2009) JAMA , vol.302 , pp. 947-954
    • Montalescot, G.1    Cayla, G.2    Collet, J.P.3    Elhadad, S.4    Beygui, F.5    Le Breton, H.6
  • 38
    • 33747874088 scopus 로고    scopus 로고
    • A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: The ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet aCtivation, inflammation and ongoing Necrosis) trial
    • Montalescot G, Sideris G, Meuleman C, Bal-dit-Sollier C, Lellouche N, Steg PG, et al. A randomized comparison of high clopidogrel loading doses in patients with non-st-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 2006;48:931-8.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 931-938
    • Montalescot, G.1    Sideris, G.2    Meuleman, C.3    Bal-dit-Sollier, C.4    Lellouche, N.5    Steg, P.G.6
  • 39
    • 82955201639 scopus 로고    scopus 로고
    • Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute st-elevation myocardial infarction
    • Dorler J, Edlinger M, Alber HF, Altenberger J, Benzer W, Grimm G, et al. Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Eur Heart J 2011;32:2954-61.
    • (2011) Eur Heart J , vol.32 , pp. 2954-2961
    • Dorler, J.1    Edlinger, M.2    Alber, H.F.3    Altenberger, J.4    Benzer, W.5    Grimm, G.6
  • 40
    • 67849083515 scopus 로고    scopus 로고
    • Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for st-elevation myocardial infarction
    • Fefer P, Hod H, Hammerman H, Segev A, Beinart R, Boyko V, et al. Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Am J Cardiol 2009;104:514-8.
    • (2009) Am J Cardiol , vol.104 , pp. 514-518
    • Fefer, P.1    Hod, H.2    Hammerman, H.3    Segev, A.4    Beinart, R.5    Boyko, V.6
  • 41
    • 24644495673 scopus 로고    scopus 로고
    • Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with st-elevation myocardial infarction treated with fibrinolytics: The PCI-CLARITY study
    • Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 2005;294:1224-32.
    • (2005) JAMA , vol.294 , pp. 1224-1232
    • Sabatine, M.S.1    Cannon, C.P.2    Gibson, C.M.3    Lopez-Sendon, J.L.4    Montalescot, G.5    Theroux, P.6
  • 42
    • 34249901220 scopus 로고    scopus 로고
    • Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): Study rationale and design
    • Zeymer U, Arntz HR, Darius H, Huber K, Senges J. Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and design. Cardiology 2007;108:265-72.
    • (2007) Cardiology , vol.108 , pp. 265-272
    • Zeymer, U.1    Arntz, H.R.2    Darius, H.3    Huber, K.4    Senges, J.5
  • 43
    • 33645507439 scopus 로고    scopus 로고
    • Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: The ISAR-REACT 2 randomized trial
    • Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 2006;295:1531-8.
    • (2006) JAMA , vol.295 , pp. 1531-1538
    • Kastrati, A.1    Mehilli, J.2    Neumann, F.J.3    Dotzer, F.4    Ten Berg, J.5    Bollwein, H.6
  • 44
    • 9144228045 scopus 로고    scopus 로고
    • A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel
    • Kastrati A, Mehilli J, Schuhlen H, Dirschinger J, Dotzer F, ten Berg JM, et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004;350:232-8.
    • (2004) N Engl J Med , vol.350 , pp. 232-238
    • Kastrati, A.1    Mehilli, J.2    Schuhlen, H.3    Dirschinger, J.4    Dotzer, F.5    Ten Berg, J.M.6
  • 45
    • 79952071585 scopus 로고    scopus 로고
    • Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: An analysis from the early Glycoprotein IIb/IIIa inhibition in patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial
    • Wang TY, White JA, Tricoci P, Giugliano RP, Zeymer U, Harrington RA, et al. Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial. Circulation 2011;123:722-30.
    • (2011) Circulation , vol.123 , pp. 722-730
    • Wang, T.Y.1    White, J.A.2    Tricoci, P.3    Giugliano, R.P.4    Zeymer, U.5    Harrington, R.A.6
  • 46
    • 55249121698 scopus 로고    scopus 로고
    • Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention
    • Bonello L, Lemesle G, De Labriolle A, Roy P, Steinberg DH, Pinto Slottow TL, et al. Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention. Am J Cardiol 2008;102:1318-22.
    • (2008) Am J Cardiol , vol.102 , pp. 1318-1322
    • Bonello, L.1    Lemesle, G.2    De Labriolle, A.3    Roy, P.4    Steinberg, D.H.5    Pinto Slottow, T.L.6
  • 47
    • 33748948717 scopus 로고    scopus 로고
    • Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting
    • Cuisset T, Frere C, Quilici J, Morange PE, Nait-Saidi L, Carvajal J, et al. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. J Am Coll Cardiol 2006;48:1339-45.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 1339-1345
    • Cuisset, T.1    Frere, C.2    Quilici, J.3    Morange, P.E.4    Nait-Saidi, L.5    Carvajal, J.6
  • 48
    • 66349137730 scopus 로고    scopus 로고
    • Clopidogrel pretreatment before primary percutaneous coronary stenting in patients with acute st-segment elevation myocardial infarction: Comparison of high loading dose (600 mg) versus low loading dose (300 mg)
    • Jung JH, Min PK, Lee SH, Sung CW, Choi S, Cho JR, et al. Clopidogrel pretreatment before primary percutaneous coronary stenting in patients with acute ST-segment elevation myocardial infarction: comparison of high loading dose (600 mg) versus low loading dose (300 mg). Coron Artery Dis 2009;20:150-4.
    • (2009) Coron Artery Dis , vol.20 , pp. 150-154
    • Jung, J.H.1    Min, P.K.2    Lee, S.H.3    Sung, C.W.4    Choi, S.5    Cho, J.R.6
  • 49
    • 77958577331 scopus 로고    scopus 로고
    • Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty
    • Mangiacapra F, Muller O, Ntalianis A, Trana C, Heyndrickx GR, Bartunek J, et al. Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 2010;106:1208-11.
    • (2010) Am J Cardiol , vol.106 , pp. 1208-1211
    • Mangiacapra, F.1    Muller, O.2    Ntalianis, A.3    Trana, C.4    Heyndrickx, G.R.5    Bartunek, J.6
  • 50
    • 79960175398 scopus 로고    scopus 로고
    • Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry
    • Lin GM, Li YH, Chu KM, Han CL.Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry. Am Heart J 2011;162:e17.
    • (2011) Am Heart J , vol.162 , pp. e17
    • Lin, G.M.1    Li, Y.H.2    Chu, K.M.3    Han, C.L.4
  • 51
    • 17744376570 scopus 로고    scopus 로고
    • Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the armyda-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study
    • Patti G, Colonna G, Pasceri V, Pepe LL, Montinaro A, Di Sciascio G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2005;111:2099-106.
    • (2005) Circulation , vol.111 , pp. 2099-2106
    • Patti, G.1    Colonna, G.2    Pasceri, V.3    Pepe, L.L.4    Montinaro, A.5    Di Sciascio, G.6
  • 52
    • 57149119456 scopus 로고    scopus 로고
    • Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary Intervention in Acute Coronary Lesions (PRACTICAL) Trial
    • Yong G, Rankin J, Ferguson L, Thom J, French J, Brieger D, et al. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial. Am Heart J 2009;157:60.e1-9.
    • (2009) Am Heart J , vol.157 , Issue.60 , pp. e1-e9
    • Yong, G.1    Rankin, J.2    Ferguson, L.3    Thom, J.4    French, J.5    Brieger, D.6
  • 53
    • 84880176319 scopus 로고    scopus 로고
    • Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: An analysis of the armyda-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) study
    • Mangiacapra F, Patti G, Barbato E, Orlic D, Peace AJ, D'Ambrosio A, et al. Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study. Int J Cardiol 2012;160:213-4.
    • (2012) Int J Cardiol , vol.160 , pp. 213-214
    • Mangiacapra, F.1    Patti, G.2    Barbato, E.3    Orlic, D.4    Peace, A.J.5    D'Ambrosio, A.6
  • 54
    • 84864838330 scopus 로고    scopus 로고
    • Effects of 600 mg versus 300 mg loading dose of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Long-term follow-up study
    • Song PS, Hahn JY, Song YB, Choi JH, Choi SH, Kang GH, et al. Effects of 600 mg versus 300 mg loading dose of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: long-term follow-up study. Yonsei Med J 2012;53:906-14.
    • (2012) Yonsei Med J , vol.53 , pp. 906-914
    • Song, P.S.1    Hahn, J.Y.2    Song, Y.B.3    Choi, J.H.4    Choi, S.H.5    Kang, G.H.6
  • 55
    • 77955640907 scopus 로고    scopus 로고
    • Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: Results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial
    • Di Sciascio G, Patti G, Pasceri V, Gatto L, Colonna G, Montinaro A. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial. J Am Coll Cardiol 2010;56:550-7.
    • (2010) J Am Coll Cardiol , vol.56 , pp. 550-557
    • Di Sciascio, G.1    Patti, G.2    Pasceri, V.3    Gatto, L.4    Colonna, G.5    Montinaro, A.6
  • 56
    • 79957967451 scopus 로고    scopus 로고
    • Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy who present with an acute coronary syndrome and undergo percutaneous coronary intervention
    • Mahmoudi M, Syed AI, Ben-Dor I, Gonzalez M, Maluenda G, Gaglia MA Jr, et al. Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy who present with an acute coronary syndrome and undergo percutaneous coronary intervention. Am J Cardiol 2011;107:1779-82.
    • (2011) Am J Cardiol , vol.107 , pp. 1779-1782
    • Mahmoudi, M.1    Syed, A.I.2    Ben-Dor, I.3    Gonzalez, M.4    Maluenda, G.5    Gaglia, M.A.6
  • 57
    • 84879843496 scopus 로고    scopus 로고
    • Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial)
    • Patti G, Pasceri V, Mangiacapra F, Colonna G, Vizzi V, Ricottini E, et al. Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial). Am J Cardiol 2013;112:162-8.
    • (2013) Am J Cardiol , vol.112 , pp. 162-168
    • Patti, G.1    Pasceri, V.2    Mangiacapra, F.3    Colonna, G.4    Vizzi, V.5    Ricottini, E.6
  • 58
    • 65549120672 scopus 로고    scopus 로고
    • Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial
    • Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA, et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2009;53:1965-72.
    • (2009) J Am Coll Cardiol , vol.53 , pp. 1965-1972
    • Ebrahimi, R.1    Dyke, C.2    Mehran, R.3    Manoukian, S.V.4    Feit, F.5    Cox, D.A.6
  • 59
    • 34447115693 scopus 로고    scopus 로고
    • Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial
    • Dery JP, Campbell ME, Mathias J, Pieper KS, Harrington RA, Madan M, et al. Complementary effects of thienopyridine pretreatment and platelet glycoprotein iib/iiia integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial. Catheter Cardiovasc Interv 2007;70:43-50.
    • (2007) Catheter Cardiovasc Interv , vol.70 , pp. 43-50
    • Dery, J.P.1    Campbell, M.E.2    Mathias, J.3    Pieper, K.S.4    Harrington, R.A.5    Madan, M.6
  • 60
    • 82955194859 scopus 로고    scopus 로고
    • Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    • Koul S, Smith JG, Schersten F, James S, Lagerqvist B, Erlinge D. Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 2011;32:2989-97.
    • (2011) Eur Heart J , vol.32 , pp. 2989-2997
    • Koul, S.1    Smith, J.G.2    Schersten, F.3    James, S.4    Lagerqvist, B.5    Erlinge, D.6
  • 61
    • 79957955953 scopus 로고    scopus 로고
    • Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry)
    • Amin AP, Kennedy KF, Pencina M, Berger P, Piana RN, Lopez J, et al. Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). Am J Cardiol 2011;107:1751-6.
    • (2011) Am J Cardiol , vol.107 , pp. 1751-1756
    • Amin, A.P.1    Kennedy, K.F.2    Pencina, M.3    Berger, P.4    Piana, R.N.5    Lopez, J.6
  • 62
    • 70349205514 scopus 로고    scopus 로고
    • Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: A comparison of two strategies
    • Davlouros PA, Arseniou A, Hahalis G, Chiladakis J, Mazarakis A, Damelou A, et al. Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies. Am Heart J 2009;158:585-91.
    • (2009) Am Heart J , vol.158 , pp. 585-591
    • Davlouros, P.A.1    Arseniou, A.2    Hahalis, G.3    Chiladakis, J.4    Mazarakis, A.5    Damelou, A.6
  • 63
    • 4444287645 scopus 로고    scopus 로고
    • Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: A REPLACE-2 substudy
    • Saw J, Lincoff AM, DeSmet W, Betriu A, Rutsch W, Wilcox RG, et al. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy. J Am Coll Cardiol 2004;44:1194-9.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 1194-1199
    • Saw, J.1    Lincoff, A.M.2    DeSmet, W.3    Betriu, A.4    Rutsch, W.5    Wilcox, R.G.6
  • 64
    • 33846202116 scopus 로고    scopus 로고
    • Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort
    • Szuk T, Gyongyosi M, Homorodi N, Kristof E, Kiraly C, Edes IF, et al. Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort. Am Heart J 2007;153:289-95.
    • (2007) Am Heart J , vol.153 , pp. 289-295
    • Szuk, T.1    Gyongyosi, M.2    Homorodi, N.3    Kristof, E.4    Kiraly, C.5    Edes, I.F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.